Expression :

Owner Public
URN urn:agi-Expression:inout-urn:agi-llid:5465:out-urn:agi-llid:345::negative
Entities APOC3 |--- PPARA
References 13
Connectivity 2
Effect negative

Organism Rattus norvegicus
Journal Endocrin. Metabol
Journal Reference v284 i4 pE841 (2003)
Journal Link http://ajpendo.physiology.org/cgi/content/full/284/4/E841
Organ liver
MedLine Reference 12475752:1258
Sentence Similarly, as for fibrates and other PPARalpha agonists that have been reported to reduce the liver expression of ApoCIII, a major component of VLDL particles, it was observed that ragaglitazar but not rosiglitazone elicited this change.

Organism Rattus norvegicus
Journal J. Biol. Chem
CellType hepatocyte
Journal Reference v276 i34 p31521 (2001)
Journal Link http://www.jbc.org/cgi/content/full/276/34/31521
MedLine Reference 11418601:1160
Sentence In addition, PPARalpha agonist treatment suppressed apo CIII mRNA at the same doses that induced FACO activity.

Journal J. Biol. Chem
Journal Reference v277 i30 p27120 (2002)
Journal Link http://www.jbc.org/cgi/content/full/277/30/27120
Organ liver
MedLine Reference 12021280:1230
Sentence Studies with PPARalpha knockout mice have clearly demonstrated that PPARalpha is required in the negative regulation of apoCIII gene expression by fibrates ( 64 ).

Organism Mus musculus
Journal JPET
Journal Reference v309 i3 p861 (2004)
Journal Link http://jpet.aspetjournals.org/cgi/content/full/309/3/861
MedLine Reference 14960661:1234
Sentence PPARalpha activation has been shown to reduce apoCIII levels in humans, thus increasing LPL activity and triglyceride hydrolysis (Staels et al., 1995 ).

Tissue skeletal muscle
Organ heart
MedLine Reference 10431661:5
Sentence The effect of fibrates on the metabolism of triglyceride-rich lipoproteins is due to a PPAR-alpha dependent stimulation of lipoprotein lipase and an inhibition of apolipoprotein C-III expressions, whereas the increase in plasma HDL cholesterol depends on an overexpression of apolipoprotein A-I and apolipoprotein A-II.

Journal Mol. Endocrin
Journal Reference v18 i6 p1321 (2004)
Tissue vascular
Journal Link http://mend.endojournals.org/cgi/content/full/18/6/1321
MedLine Reference 15087471:1123
Sentence Both PPARalpha and PPARgamma modulate the lipoprotein serum profile via increased expression of lipoprotein lipase (LPL) (reviewed in Ref. 48 ) and decreased expression of apolipoprotein (apo)CIII, an inhibitor of LPL activity.

Organism Mus musculus
Journal J. Biol. Chem
Journal Reference v276 i44 p41293 (2001)
Journal Link http://www.jbc.org/cgi/content/full/276/44/41293
Organ liver
MedLine Reference 11546766:1219
Sentence PPARalpha activation by fibrates lowers plasma triglyceride ( 28 ) and represses apoCIII ( 28 ) and Aalpha-fibrinogen expression ( 49 ).

Tissue fat
MedLine Reference 9361824:9
Sentence PPAR directly activates genes like AOX, but also inhibits transcription of genes like S14, FAS, apolipoprotein CIII, transferrin.

Organ liver
MedLine Reference 10774955:6
Sentence Upon fibrate activation, PPARalpha down-regulates hepatic apolipoprotein C-III and increases lipoprotein lipase gene expression, key players in triglyceride metabolism.

Journal Endocrinology
Journal Reference v144 i6 p2201 (1997)
Journal Link http://endo.endojournals.org/cgi/content/full/144/6/2201
MedLine Reference 12746275:1054
Sentence PPARalpha has also been shown to down-regulate apolipoprotein C-III, a protein which inhibits TG hydrolysis by LPL.

Journal J. Biol. Chem
CellType hepatocyte
Journal Reference v278 i20 p17982 (2003)
Journal Link http://www.jbc.org/cgi/content/full/278/20/17982
MedLine Reference 12637506:1119

Organism Rattus norvegicus
Journal Mol. Pharm
CellType hepatocyte
Journal Reference v54 i3 p463 (1998)
Journal Link http://molpharm.aspetjournals.org/cgi/content/full/54/3/463
Organ liver
MedLine Reference 9730905:1317

Organism Mus musculus
Journal J. Biol. Chem
Journal Reference v273 i10 p5678 (1998)
Journal Link http://www.jbc.org/cgi/content/full/273/10/5678
MedLine Reference 9488698:1169